已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications

医学 超声造影 放射科 双雷达 置信区间 超声波 超声科 乳腺摄影术 诊断准确性 乳房成像 乳腺癌 内科学 癌症
作者
Meng-Fu Cheng,Wenjuan Tong,Jia Luo,M. Li,Jinyu Liang,Faming Pan,Jingxue Pan,Yanling Zheng,Xiaoyan Xie
出处
期刊:Clinical Radiology [Elsevier BV]
卷期号:75 (12): 934-941 被引量:9
标识
DOI:10.1016/j.crad.2020.07.017
摘要

•Classifying suspicious lesions with calcifications remains a dilemma on US. •CEUS is a valuable tool in the evaluation of breast lesions with calcifications. •CEUS-BI-RADS showed better results than US on breast lesions with calcifications. •CEUS was effective in the diagnosis of isolated microcalcifications without mass. Aim To evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for Breast Imaging-Reporting and Data System for Ultrasound (US-BI-RADS) 3 and 4 lesions with calcifications. Materials and methods A retrospective study of 168 breast lesions with calcifications detected on both mammography and conventional ultrasonography (US) in 152 patients were categorised as US-BI-RADS 3–4 at US between June 2009 and June 2018. CEUS scores were obtained based on a CEUS five-point scoring system. The combination of US-BI-RADS and CEUS scores created the Rerated BI-RADS (referred to as CEUS-BI-RADS). All results were compared with the histological findings. The diagnostic performances of US and CEUS-BI-RADS were compared. Results The diagnostic sensitivity, specificity, and accuracy of US were 81.8% (95% confidence interval [CI]: 71.6%, 92%), 85% (95% CI: 78.4%, 91.5%), and 83.9% (95% CI: 78.4%, 89.5%), respectively, while those for CEUS-BI-RADS were 98.2% (95% CI: 94.7%, 100%), 90.3% (95% CI: 84.8%, 95.7%), and 92.9% (95% CI: 89%, 96.8%), respectively. The diagnostic sensitivity and accuracy values of CEUS-BI-RADS greatly improved compared with those of US (p=0.003 and p=0.004, respectively). The areas under the receiver operating characteristic (ROC) curves for US and CEUS-BI-RADS were 0.888 (95% CI: 0.840, 0.936) and 0.963 (95% CI: 0.936, 0.989), respectively. The diagnostic efficacy of CEUS-BI-RADS was significantly higher than that of US alone (p=0.004). Conclusion CEUS-BI-RADS significantly improves the diagnostic accuracy for breast US-BI-RADS 3 and 4 lesions with calcifications compared with US. To evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for Breast Imaging-Reporting and Data System for Ultrasound (US-BI-RADS) 3 and 4 lesions with calcifications. A retrospective study of 168 breast lesions with calcifications detected on both mammography and conventional ultrasonography (US) in 152 patients were categorised as US-BI-RADS 3–4 at US between June 2009 and June 2018. CEUS scores were obtained based on a CEUS five-point scoring system. The combination of US-BI-RADS and CEUS scores created the Rerated BI-RADS (referred to as CEUS-BI-RADS). All results were compared with the histological findings. The diagnostic performances of US and CEUS-BI-RADS were compared. The diagnostic sensitivity, specificity, and accuracy of US were 81.8% (95% confidence interval [CI]: 71.6%, 92%), 85% (95% CI: 78.4%, 91.5%), and 83.9% (95% CI: 78.4%, 89.5%), respectively, while those for CEUS-BI-RADS were 98.2% (95% CI: 94.7%, 100%), 90.3% (95% CI: 84.8%, 95.7%), and 92.9% (95% CI: 89%, 96.8%), respectively. The diagnostic sensitivity and accuracy values of CEUS-BI-RADS greatly improved compared with those of US (p=0.003 and p=0.004, respectively). The areas under the receiver operating characteristic (ROC) curves for US and CEUS-BI-RADS were 0.888 (95% CI: 0.840, 0.936) and 0.963 (95% CI: 0.936, 0.989), respectively. The diagnostic efficacy of CEUS-BI-RADS was significantly higher than that of US alone (p=0.004). CEUS-BI-RADS significantly improves the diagnostic accuracy for breast US-BI-RADS 3 and 4 lesions with calcifications compared with US.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
三井库里发布了新的文献求助10
1秒前
念初发布了新的文献求助10
2秒前
桐桐应助水之冬采纳,获得10
3秒前
4秒前
废式脂肪发布了新的文献求助10
7秒前
7秒前
今后应助hhhi采纳,获得10
9秒前
迷路翠绿发布了新的文献求助10
11秒前
漂亮白枫发布了新的文献求助10
12秒前
废式脂肪完成签到,获得积分10
14秒前
NexusExplorer应助三井库里采纳,获得10
15秒前
顾矜应助桀桀桀采纳,获得10
18秒前
20秒前
20秒前
24秒前
今后应助漂亮白枫采纳,获得10
27秒前
29秒前
ruler发布了新的文献求助10
31秒前
桀桀桀发布了新的文献求助10
32秒前
一直向前发布了新的文献求助10
34秒前
bkagyin应助Karol采纳,获得10
34秒前
35秒前
36秒前
ZGH完成签到,获得积分10
36秒前
小二郎应助是小小李哇采纳,获得10
37秒前
cgg完成签到 ,获得积分10
39秒前
40秒前
杰jj发布了新的文献求助10
40秒前
英俊的铭应助科研通管家采纳,获得10
40秒前
orixero应助WuYiHHH采纳,获得10
40秒前
完美世界应助科研通管家采纳,获得10
40秒前
科研通AI5应助科研通管家采纳,获得10
40秒前
科研通AI5应助科研通管家采纳,获得10
40秒前
我是老大应助科研通管家采纳,获得10
40秒前
科研通AI2S应助科研通管家采纳,获得10
40秒前
上官若男应助科研通管家采纳,获得10
40秒前
41秒前
42秒前
念初完成签到 ,获得积分10
42秒前
42秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989918
求助须知:如何正确求助?哪些是违规求助? 3532013
关于积分的说明 11255831
捐赠科研通 3270829
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882233
科研通“疑难数据库(出版商)”最低求助积分说明 809216